lysophosphatidic acid has been researched along with docetaxel anhydrous in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, MW; Altman, MK; Callihan, P; Hooks, SB; Hurst, JH; Murph, MM | 1 |
1 other study(ies) available for lysophosphatidic acid and docetaxel anhydrous
| Article | Year |
|---|---|
Regulators of G-Protein signaling RGS10 and RGS17 regulate chemoresistance in ovarian cancer cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Cisplatin; Computational Biology; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; Lysophospholipids; Ovarian Neoplasms; Polymerase Chain Reaction; RGS Proteins; Signal Transduction; Taxoids; Vincristine | 2010 |